Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model

被引:91
作者
Bertaina-Anglade, Valerie
la Rochelle, Christophe Drieu
Boyer, Pierre-Alain
Mocaer, Elisabeth
机构
[1] Biotrial, Dept Preclin Pharmacol, F-35000 Rennes, France
[2] Inst Rech Int Servier, F-92415 Courbevoie, France
来源
BEHAVIOURAL PHARMACOLOGY | 2006年 / 17卷 / 08期
关键词
agomelatine; antidepressant; imipramine; learned helplessness; melatonin; rat;
D O I
10.1097/FBP.0b013e3280116e5c
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
To confirm the antidepressant-like activity of agomelatine (S 20098), a melatonin agonist and 5-hydroxytryptamine(2c) antagonist, already reported in the chronic mild stress and forced swimming tests, the effects of agomelatine were investigated in the learned helplessness test and compared with those of imipramine, melatonin and a selective 5-hydroxytryptamine(2c) antagonist, SB-242084. Agomelatine was administered for 5 days either once a day or twice a day, and the effects of pretreatment by a melatonin receptor antagonist, S 22153 (20 mg/kg/day), were studied. A deficit in avoidance learning was observed in helpless control animals. Agomelatine (10 mg/kg/day) administered once a day significantly reduced this deficit with an effect similar to that of imipramine. Effects of agomelatine were abolished by S 22153 pretreatment. Melatonin or SB-242084 did not reduce the deficit of helpless control animals. These results confirm the antidepressant-like activity of agomelatine and suggest a role of melatonin receptors in its mechanism of action. Behavioural Pharmacology 17:703-713 (c) 2006 Lippincott Williams & Wilkins.
引用
收藏
页码:703 / 713
页数:11
相关论文
共 57 条
[51]   Comparative effects of a melatonin agonist on the circadian system in mice and Syrian hamsters [J].
VanReeth, O ;
Olivares, E ;
Zhang, Y ;
Zee, PC ;
Mocaer, E ;
Defrance, R ;
Turek, FW .
BRAIN RESEARCH, 1997, 762 (1-2) :185-194
[52]   CIRCADIAN-RHYTHM MECHANISMS IN AFFECTIVE-ILLNESS AND IN ANTI-DEPRESSANT DRUG-ACTION [J].
WEHR, TA ;
WIRZJUSTICE, A .
PHARMACOPSYCHIATRIA, 1982, 15 (01) :31-39
[53]   A melatonin agonist facilitates circadian resynchronization in old hamsters after abrupt shifts in the light-dark cycle [J].
Weibel, L ;
Turek, FW ;
Mocaer, E ;
Van Reeth, O .
BRAIN RESEARCH, 2000, 880 (1-2) :207-211
[54]   Apheresis technology for prevention and regression of atherosclerosis [J].
Yamamoto, A ;
Harada-Shiba, M ;
Kawaguchi, A ;
Tsushima, M .
THERAPEUTIC APHERESIS, 2001, 5 (04) :221-225
[55]   Melatonin analogues as agonists and antagonists in the circadian system and other brain areas [J].
Ying, SW ;
Rusak, B ;
Delagrange, P ;
Mocaer, E ;
Renard, P ;
GuardiolaLemaitre, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 296 (01) :33-42
[56]   Chronic exposure to melatonin receptor agonists does not alter their effects on suprachiasmatic nucleus neurons [J].
Ying, SW ;
Rusak, B ;
Mocaër, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 342 (01) :29-37
[57]   NOVEL NAPHTHALENIC LIGANDS WITH HIGH-AFFINITY FOR THE MELATONIN RECEPTOR [J].
YOUS, S ;
ANDRIEUX, J ;
HOWELL, HE ;
MORGAN, PJ ;
RENARD, P ;
PFEIFFER, B ;
LESIEUR, D ;
GUARDIOLALEMAITRE, B .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (08) :1484-1486